HopeStage
Back to all studies
RecruitingNCT06675851

Antidepressants, brain dopamine and reward in depression

About this titleRead the official source — NCT06675851
Medication studyAges 18–65Austria
The study in practice

Understand this study

Who could participate?

This study is for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
ViennaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
Medical University of Vienna
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Austria
Age range
From 18 Years to 65 Years
Official registry ID
NCT06675851
Official title
Show the full official title

Reward-specific Changes of Cerebral Dopamine Synthesis in Healthy Volunteers and Depressed Patients

Recruitment & locations

Currently recruiting

Vienna

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of Vienna, a university.

Does this study involve medication?

Yes. The study involves medication, including WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline and Cipralex (escitalopram).

Who can participate?

This study is for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies